This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2025 Remove Energy Remove IT partnerships Related Topics
Collaboration Legal Ecosystems Biopharmaceuticals Biopharma Biotechnology Life science Government Construction Engineering More Related Topics >
article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

APRIL 3, 2024

Fuelling Growth: Strategic Investments, Acquisitions, and Expansions Samsung Biologics unveiled plans to expand capacity and geographic reach by initiating the construction of Bio Campus II with a $6 billion investment scheduled to begin operations in 2025 while completing its CGMP antibody-drug conjugate manufacturing facility within 2024.

Biopharmaceuticals 59
Biopharmaceuticals Biopharma Biotechnology Life science 59
article thumbnail

Ongoing Market Consolidation Points at the Booming Video Opportunity

Frost & Sullivan

APRIL 7, 2022

So what can businesses do to draw employees back to the office where they can benefit from the in-person energy, creativity, and serendipitous conversations? This number will grow nearly three times by 2025. Many employees are simply unwilling to go back to the office. The old meeting room concept is indeed dead.

Engineering 98
Engineering Collaboration Energy Ecosystems 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 93,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024